rosiglitazone has been researched along with Colitis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Da Silva, S; Keita, ÅV; Mattson, JP; Mohlin, S; Påhlman, I; Påhlman, S; Söderholm, JD; Theodorou, V | 1 |
| Cheng, L; Yang, J; Zhao, J; Zhao, R; Zhu, L | 1 |
| Ge, S; Qian, J; Shao, Z; Wang, J; Wang, L; Wang, W; Xie, Q; Zhang, C; Zhou, C; Zuo, L | 1 |
| Brzozowski, T; Celinski, K; Dworzanski, T; Fornal, R; Korolczuk, A; Madro, A; Slomka, M | 1 |
| Celinski, K; Cichoz-Lach, H; Czechowska, G; Dworzanski, T; Korolczuk, A; Madro, A; Radej, S; Slomka, M | 1 |
| Celinski, K; Dworzanski, T; Fornal, R; Korolczuk, A; Madro, A; Piasecki, R; Slomka, M | 1 |
| Celinski, K; Dworzanski, T; Fornal, R; Korolczuk, A; Madro, A; Slomka, M | 1 |
| Aburatani, H; Blumberg, RS; Kadowaki, T; Matsuhashi, N; Nagai, R; Nakajima, A; Saubermann, LJ; Terauchi, Y; Wada, K; Zhao, S | 1 |
| Alarcón De La Lastra, C; Martín, AR; Sánchez-Hidalgo, M; Villegas, I | 1 |
| Adachi, M; Gonzalez, FJ; Gumucio, DL; Kurotani, R; Madison, BB; Marin, HE; Morimura, K; Peters, JM; Sanford, M; Shah, Y; Young, HA | 1 |
| Gonzalez, FJ; Morimura, K; Shah, YM | 1 |
| Benight, N; Denson, LA; Frank, SJ; Han, X; Loesch, K; Osuntokun, B | 1 |
| Alou, L; Caso, JR; Colón, A; Cos, E; Gómez-Lus, ML; Leza, JC; Lizasoain, I; Lorenzo, P; Menchén, L; Menchén, P; Moro, MA; Ponferrada, A; Sevillano, D | 1 |
| Mensink, RP; Plat, J; Ramakers, JD; Te Velde, AA; Thuijls, G; Verstege, MI | 1 |
| Bailey, ST; Flanigan, A; Jiang, W; Keilbaugh, SA; Lazar, MA; Murthy, S; Rangwala, SM; Su, CG; Wen, X; Wu, GD | 1 |
| Blumberg, RS; Kadowaki, T; Kubota, N; Matsuhashi, N; Miki, H; Nagai, R; Nakajima, A; Nakajima, N; Ohnishi, S; Saubermann, LJ; Terauchi, Y; Wada, K | 1 |
| Auwerx, J; Chambon, P; Colombel, JF; Derijard, B; Desreumaux, P; Desvergne, B; Dubuquoy, L; Englaro, W; Leibowitz, MD; Nutten, S; Peuchmaur, M; Schoonjans, K; Wahli, W | 1 |
17 other study(ies) available for rosiglitazone and Colitis
| Article | Year |
|---|---|
A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
Topics: Adult; Aged; Animals; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Female; Humans; Intestinal Mucosa; Male; Mice, Inbred BALB C; Middle Aged; Perilipin-2; Peroxidase; PPAR gamma; Rosiglitazone; Trinitrobenzenesulfonic Acid | 2018 |
Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model.
Topics: Animals; Caco-2 Cells; Colitis; Dextran Sulfate; Disease Models, Animal; HT29 Cells; Humans; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mucin-2; Mucus; Myosin-Light-Chain Kinase; Permeability; Phosphorylation; PPAR gamma; Rosiglitazone; Signal Transduction; Tight Junctions | 2018 |
[Rosiglitazone ameliorates TNBS-induced colitis in mice by inhibiting inflammation of the mesenteric adipose tissues].
Topics: Adipose Tissue; Animals; Colitis; Cytokines; Inflammation; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Rats; Rosiglitazone; Trinitrobenzenesulfonic Acid | 2018 |
Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis.
Topics: Animals; Anti-Inflammatory Agents; Chromans; Colitis; Colon; Cytokines; Dextran Sulfate; Intestinal Mucosa; Male; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Troglitazone | 2013 |
Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
Topics: Animals; Benzhydryl Compounds; Colitis; Cytokines; Epoxy Compounds; Intestine, Large; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2010 |
Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Carcinogens; Colitis; Colon; Cytokines; Dextran Sulfate; Epoxy Compounds; Hypoglycemic Agents; Intestinal Mucosa; Intestine, Large; Ligands; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2011 |
Comparison of the anti-inflammatory and therapeutic actions of PPAR-gamma agonists rosiglitazone and troglitazone in experimental colitis.
Topics: Animals; Anti-Inflammatory Agents; Chromans; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Agents; Inflammation Mediators; Interleukin-10; Interleukin-2; Interleukin-4; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Troglitazone | 2012 |
Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
Topics: Acute Disease; Animals; Antibody Formation; Antioxidants; Chromans; Colitis; Cytokines; Disease Models, Animal; Hypoglycemic Agents; Ligands; Mice; Mice, Inbred C57BL; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Th2 Cells; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
Topics: Animals; Apoptosis; Chronic Disease; Colitis; Cyclooxygenase 1; Cyclooxygenase 2; Female; Immunohistochemistry; Male; Membrane Proteins; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2005 |
Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Topics: Animals; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Susceptibility; Epithelial Cells; Female; Inflammatory Bowel Diseases; Intestinal Mucosa; Ligands; Mice; Mice, Transgenic; Polymerase Chain Reaction; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2006 |
Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blotting, Western; Body Weight; CD36 Antigens; Cell Movement; Chemokine CCL2; Colitis; Colon; Cytokines; Dendritic Cells; Dextran Sulfate; Fatty Acid-Binding Proteins; Gene Expression; Macrophages; Mice; Mice, Inbred Strains; Mice, Knockout; Neutrophils; Nitric Oxide Synthase Type II; PPAR gamma; Receptors, CCR2; Receptors, Chemokine; Receptors, Immunologic; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2007 |
Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.
Topics: Animals; Carrier Proteins; Child; Colitis; Colon; Crohn Disease; Epithelial Cells; Female; Genetic Predisposition to Disease; Humans; Hypoglycemic Agents; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mucous Membrane; NF-kappa B; PPAR gamma; Rosiglitazone; Signal Transduction; STAT5 Transcription Factor; Thiazolidinediones; Trinitrobenzenesulfonic Acid | 2006 |
The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction.
Topics: Animals; Bacterial Translocation; Benzamides; Colitis; Colon; Corticosterone; Cyclooxygenase 2; Gene Expression Regulation, Enzymologic; Homeostasis; Intestinal Absorption; Ligands; Male; Nitric Oxide Synthase Type II; Peroxidase; PPAR gamma; Prostaglandin D2; Pyridines; Rats; Rats, Wistar; Restraint, Physical; Rosiglitazone; Stress, Physiological; Thiazolidinediones | 2007 |
The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
Topics: Animals; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Female; Membrane Proteins; Mice; Mice, Inbred C57BL; Peroxidase; Phosphoproteins; PPAR gamma; Rosiglitazone; Serum Amyloid P-Component; Spleen; Thiazolidinediones; Zonula Occludens-1 Protein | 2007 |
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.
Topics: Animals; Caco-2 Cells; Colitis; Cytokines; DNA-Binding Proteins; Epithelium; Gene Expression; HT29 Cells; Humans; I-kappa B Proteins; Inflammation; Inflammatory Bowel Diseases; Interleukin-8; Ligands; Mice; Microbodies; NF-kappa B; NF-KappaB Inhibitor alpha; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |
Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury.
Topics: Animals; Cells, Cultured; Colitis; Epithelial Cells; Gastric Mucosa; Gene Expression; Hypoglycemic Agents; In Vitro Techniques; Intercellular Adhesion Molecule-1; Interleukin-8; Intestinal Mucosa; L-Lactate Dehydrogenase; Liver; Mice; Mice, Inbred BALB C; Mice, Knockout; NF-kappa B; Peroxidase; Pneumonia; Receptors, Cytoplasmic and Nuclear; Reperfusion Injury; RNA, Messenger; Rosiglitazone; Stomach; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
Topics: Animals; Colitis; Dimerization; Drug Synergism; Mice; Mice, Mutant Strains; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Trinitrobenzenesulfonic Acid | 2001 |